Premium
Igniting Small‐Molecule Drug Discovery
Author(s) -
Steinhagen Henning
Publication year - 2016
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.201500580
Subject(s) - medicine , anakinra , canakinumab , psoriasis , rheumatoid arthritis , tocilizumab , biosimilar , drug discovery , inflammatory bowel disease , immunology , drug , etanercept , infliximab , tumor necrosis factor alpha , disease , pharmacology , bioinformatics , biology
Small molecules at work : The articles in this special issue illustrate the significant advances made in the field of autoimmune and inflammatory diseases. The small molecules described have the potential to reach or surpass the efficacy of biologics in current use, and to address diseases for which biologics have no impact. Scientific efforts driven by medicinal chemistry will ultimately pave the way for new medicines to benefit patients suffering from immune‐mediated inflammatory disorders.